Disposition of intravenously administered adenosine 5′-phosphosulfate (APS) in rats

Ken Iwata, Kazumi Matsuda, Yuji Kurosaki, Taiji Nakayama, Hiroshi Nakajima, Toshikiro Kimura

Research output: Contribution to journalArticle

Abstract

The disposition of adenosine 5′-phosphosulfate (APS), an endogenous nucleotide, was investigated in rats. The degradation of APS in rat plasma was very rapid. APS was degraded in rat plasma to AMP and ATP, and these nucleotides were further degraded through adenosine. The degradation kinetics was examined. For the in vivo study, the method to protect APS front degradation in blood was examined, and it was found that the addition of EDTA to APS-containing blood and storage at 4 °C can protect against APS degradation. After intravenous bolus injection, APS in plasma declined rapidly and the rate of elimination was dose-dependent: the biological half-life was about 2s at the dose of 0.3mg/kg and was longer at 3 mg/kg. When APS was administered by intravenous infusion, the plasma level rapidly reached a steady-state, which then rapidly declined after the infusion was stopped. The total body clearance of APS could not be fully explained by metabolism in plasma or glomerular filtration, therefore the contribution of other elimination processes to the total body clearance was suggested.

Original languageEnglish
Pages (from-to)438-443
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume19
Issue number3
Publication statusPublished - Mar 1996

Fingerprint

Adenosine Phosphosulfate
Nucleotides
Adenosine Monophosphate
Intravenous Infusions
Edetic Acid
Intravenous Injections
Adenosine
Half-Life
Adenosine Triphosphate

Keywords

  • Adenosine 5′-phosphosulfate
  • APS
  • Kinetic analysis
  • Plasma degradation
  • Rat

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Iwata, K., Matsuda, K., Kurosaki, Y., Nakayama, T., Nakajima, H., & Kimura, T. (1996). Disposition of intravenously administered adenosine 5′-phosphosulfate (APS) in rats. Biological and Pharmaceutical Bulletin, 19(3), 438-443.

Disposition of intravenously administered adenosine 5′-phosphosulfate (APS) in rats. / Iwata, Ken; Matsuda, Kazumi; Kurosaki, Yuji; Nakayama, Taiji; Nakajima, Hiroshi; Kimura, Toshikiro.

In: Biological and Pharmaceutical Bulletin, Vol. 19, No. 3, 03.1996, p. 438-443.

Research output: Contribution to journalArticle

Iwata, K, Matsuda, K, Kurosaki, Y, Nakayama, T, Nakajima, H & Kimura, T 1996, 'Disposition of intravenously administered adenosine 5′-phosphosulfate (APS) in rats', Biological and Pharmaceutical Bulletin, vol. 19, no. 3, pp. 438-443.
Iwata, Ken ; Matsuda, Kazumi ; Kurosaki, Yuji ; Nakayama, Taiji ; Nakajima, Hiroshi ; Kimura, Toshikiro. / Disposition of intravenously administered adenosine 5′-phosphosulfate (APS) in rats. In: Biological and Pharmaceutical Bulletin. 1996 ; Vol. 19, No. 3. pp. 438-443.
@article{d3e69ef74a8c4459a467868adc00b24c,
title = "Disposition of intravenously administered adenosine 5′-phosphosulfate (APS) in rats",
abstract = "The disposition of adenosine 5′-phosphosulfate (APS), an endogenous nucleotide, was investigated in rats. The degradation of APS in rat plasma was very rapid. APS was degraded in rat plasma to AMP and ATP, and these nucleotides were further degraded through adenosine. The degradation kinetics was examined. For the in vivo study, the method to protect APS front degradation in blood was examined, and it was found that the addition of EDTA to APS-containing blood and storage at 4 °C can protect against APS degradation. After intravenous bolus injection, APS in plasma declined rapidly and the rate of elimination was dose-dependent: the biological half-life was about 2s at the dose of 0.3mg/kg and was longer at 3 mg/kg. When APS was administered by intravenous infusion, the plasma level rapidly reached a steady-state, which then rapidly declined after the infusion was stopped. The total body clearance of APS could not be fully explained by metabolism in plasma or glomerular filtration, therefore the contribution of other elimination processes to the total body clearance was suggested.",
keywords = "Adenosine 5′-phosphosulfate, APS, Kinetic analysis, Plasma degradation, Rat",
author = "Ken Iwata and Kazumi Matsuda and Yuji Kurosaki and Taiji Nakayama and Hiroshi Nakajima and Toshikiro Kimura",
year = "1996",
month = "3",
language = "English",
volume = "19",
pages = "438--443",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "3",

}

TY - JOUR

T1 - Disposition of intravenously administered adenosine 5′-phosphosulfate (APS) in rats

AU - Iwata, Ken

AU - Matsuda, Kazumi

AU - Kurosaki, Yuji

AU - Nakayama, Taiji

AU - Nakajima, Hiroshi

AU - Kimura, Toshikiro

PY - 1996/3

Y1 - 1996/3

N2 - The disposition of adenosine 5′-phosphosulfate (APS), an endogenous nucleotide, was investigated in rats. The degradation of APS in rat plasma was very rapid. APS was degraded in rat plasma to AMP and ATP, and these nucleotides were further degraded through adenosine. The degradation kinetics was examined. For the in vivo study, the method to protect APS front degradation in blood was examined, and it was found that the addition of EDTA to APS-containing blood and storage at 4 °C can protect against APS degradation. After intravenous bolus injection, APS in plasma declined rapidly and the rate of elimination was dose-dependent: the biological half-life was about 2s at the dose of 0.3mg/kg and was longer at 3 mg/kg. When APS was administered by intravenous infusion, the plasma level rapidly reached a steady-state, which then rapidly declined after the infusion was stopped. The total body clearance of APS could not be fully explained by metabolism in plasma or glomerular filtration, therefore the contribution of other elimination processes to the total body clearance was suggested.

AB - The disposition of adenosine 5′-phosphosulfate (APS), an endogenous nucleotide, was investigated in rats. The degradation of APS in rat plasma was very rapid. APS was degraded in rat plasma to AMP and ATP, and these nucleotides were further degraded through adenosine. The degradation kinetics was examined. For the in vivo study, the method to protect APS front degradation in blood was examined, and it was found that the addition of EDTA to APS-containing blood and storage at 4 °C can protect against APS degradation. After intravenous bolus injection, APS in plasma declined rapidly and the rate of elimination was dose-dependent: the biological half-life was about 2s at the dose of 0.3mg/kg and was longer at 3 mg/kg. When APS was administered by intravenous infusion, the plasma level rapidly reached a steady-state, which then rapidly declined after the infusion was stopped. The total body clearance of APS could not be fully explained by metabolism in plasma or glomerular filtration, therefore the contribution of other elimination processes to the total body clearance was suggested.

KW - Adenosine 5′-phosphosulfate

KW - APS

KW - Kinetic analysis

KW - Plasma degradation

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0029876998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029876998&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 438

EP - 443

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 3

ER -